|
2.6 Etiologie - Environnement
|
|
|
|
2.9 Etiologie - Tabac
|
|
|
|
3.1 Prévention - Tabac
|
|
|
|
3.7 Prévention - Alcool
|
|
|
|
3.8 Prévention - Alimentation
|
|
|
|
4.12 Biopsies liquides
|
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
|
4.9 Dép., diag. & prono. - Sein
|
|
|
|
5. Traitements
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.12.1 Immunothérapies - partenariats
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
|
5.12.5 Immunothérapies - Pharma
|
|
|
AstraZeneca Wins in Cancer by Going Its Own Way [Bloomberg]
|
|
|
|
|
|
There's
a troubling tendency in this market for companies to ape each other and
run the same types of studies in the same cancers, afraid of ceding
markets to their competitors. Trekking alone into the clinical-trial
unknown can feel riskier. But the rewards are far higher.
|
|
|
|
|
|
|
5.12.6 Immunothérapies - AMM
|
|
|
|
5.12.8 Immunothérapies - Economie
|
|
|
|
5.2 Pharma
|
|
|
Pharma’s five favorite tricks to protect a monopoly [STAT]
|
|
|
|
|
|
Here’s
a new one: Allergan, hoping to protect its blockbuster eye drug from a
patent challenge, sold the intellectual property to a Native American
tribe. Because that tribe has sovereignty in the U.S., Allergan’s
patents are now theoretically immune from certain types of patent
challenges.
|
|
|
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
How the EU regulates medicines [EMA]
|
|
|
|
|
|
The
European Medicines Agency (EMA) will host an awareness session to
present the European Union’s (EU) medicines regulatory system and EMA’s
role in it to international regulators and non-governmental
organisations.
|
|
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
|
|
|
5.6 ESMO
|
|
|
|
|
5.6.11 ESMO- Rein
|
|
|
|
5.6.14 ESMO - Ovaire
|
|
|
|
5.6.15 ESMO - VADS
|
|
|
|
|
|
|
5.6.16 ESMO - Appareil digestif
|
|
|
|
5.6.4 ESMO - Poumon
|
|
|
|
5.6.5 ESMO - Mélanome & Peau
|
|
|
|
|
|
|
|
5.6.7 ESMO - Immunothérapies
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.1 Observation
|
|
|
|
6.11 Patients
|
|
|
|
6.6 Publications
|
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
Merck to co-lead Big Data alliance [PharmaTimes]
|
|
|
|
|
|
Merck
will join forces with Project Data Sphere – an independent,
not-for-profit initiative of the CEO Roundtable on Cancer's Life
Sciences Consortium – to jointly lead the Global Oncology Big Data
Alliance (GOBDA).
| |
|
|
|
IBM Watson versus cancer: Hype meets reality [Science-Based Medicine]
|
|
|
|
|
|
Five
years ago, IBM announced that its supercomputer Watson revolutionize
cancer treatment by using its artificial intelligence to digest and
distill the thousands of oncology studies published every year plus
patient-level data and expert recommendations into treatment
recommendation. Last week, a report published by STAT News shows that,
years later, IBM’s hubris and hype have crashed into reality.
| |
|
|
|
6.9 Controverses
|
|
|